Plus Therapeutics Inc (PSTV) support and resistance · P/E 0.2, rev $5.8M
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
This page maps Plus Therapeutics Inc (PSTV) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
PSTV currently screens at market cap $29.7M and trailing P/E 0.2. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PSTV 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PSTV quote page for the session range and the stock page for the full model.
Not investment advice.